888
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

HLA-DR peptide occupancy can be regulated with a wide variety of small molecules

, , , , , , , , , & show all
Pages 593-598 | Received 17 Jun 2015, Accepted 28 Aug 2015, Published online: 05 May 2016

References

  • Accolla RS, Scarpellino L, Carra G, Guardiola J, Trans-acting element(s) operating across species barriers positively regulate expression of major histocompatibility complex class II genes. J Exp Med 1985; 162:1117-33; PMID:3862745; http://dx.doi.org/10.1084/jem.162.4.1117
  • Belaaouaj A, Shipley JM, Kobayashi DK, Zimonjic DB, Popescu N, Silverman GA, Shapiro SD. Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J Biol Chem 1995; 270:14568-75; PMID:7782320; http://dx.doi.org/10.1074/jbc.270.24.14568
  • Cronin K, Escobar H, Szekeres K, Reyes-Vargas E, Rockwood AL, Lloyd MC, Delgado JC, Blanck G. Regulation of HLA-DR peptide occupancy by histone deacetylase inhibitors. Hum Vaccines Immunother 2013; 9:784-9; PMID:23328677; http://dx.doi.org/10.4161/hv.23085
  • Dana D, De S, Rathod P, Davalos AR, Novoa DA, Paroly S, Torres VM, Afzal N, Lankalapalli RS, Rotenberg SA, Chang EJ, Subramaniam G, Kumar S. Development of a highly potent, selective, and cell-active inhibitor of cysteine cathepsin L-A hybrid design approach. Chem Commun 2014; 50:10875-8; PMID:25089379; http://dx.doi.org/10.1039/C4CC04037F
  • Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 1995; 82:155-65; PMID:7606781; http://dx.doi.org/10.1016/0092-8674(95)90061-6
  • Guncar G, Pungercic G, Klemencic I, Turk V, Turk D. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. EMBO J 1999; 18:793-803; PMID:10022822; http://dx.doi.org/10.1093/emboj/18.4.793
  • Loosmore S, Gladstone P, Pious D, Jerry LM, Tamaoki T. Control of HLA-DR antigen gene expression at the pretranslational level: comparison of an HLA-DR-positive B lymphoblastoid cell line and its HLA-DR-negative variant. Immunogenetics 1982; 15:139-50; PMID:6800948; http://dx.doi.org/10.1007/BF00621947
  • Matsunaga Y, Saibara T, Kido H, Katunuma N, Participation of cathepsin B in processing of antigen presentation to MHC class II. FEBS Lett 1993; 324:325-30; PMID:8405375; http://dx.doi.org/10.1016/0014-5793(93)80144-J
  • Mauro JA, Blanck G. Functionally distinct gene classes as bigger or smaller transcription factor traps: a possible stochastic component to sequential gene expression programs in cancer. Gene 2014; 536:398-406; PMID:24291030; http://dx.doi.org/10.1016/j.gene.2013.11.013
  • Pluger EB, Boes M, Alfonso C, Schroter CJ, Kalbacher H, Ploegh HL, Driessen C. Specific role for cathepsin S in the generation of antigenic peptides in vivo. Euro J Immunol 2002; 32:467-76; PMID:11813165; http://dx.doi.org/10.1002/1521-4141(200202)32:2%3c467::AID-IMMU467%3e3.0.CO;2-Y
  • Riese RJ, Mitchell RN, Villadangos JA, Shi GP, Palmer JT, Karp ER, De Sanctis GT, Ploegh HL, Chapman HA. Cathepsin S activity regulates antigen presentation and immunity. J Clin Investigat 1998; 101:2351-63; PMID:9616206; http://dx.doi.org/10.1172/JCI1158
  • Riese RJ, Wolf PR, Bromme D, Natkin LR, Villadangos JA, Ploegh HL, Chapman HA. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996; 4:357-66; PMID:8612130; http://dx.doi.org/10.1016/S1074-7613(00)80249-6
  • Shapiro SD, Kobayashi DK, Ley TJ. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 1993; 268:23824-9; PMID:8226919
  • Villadangos JA, Bryant RA, Deussing J, Driessen C, Lennon-Dumenil AM, Riese RJ, Roth W, Saftig P, Shi GP, Chapman HA, et al. Proteases involved in MHC class II antigen presentation. Immunol Rev 1999; 172 109-20; PMID:10631941; http://dx.doi.org/10.1111/j.1600-065X.1999.tb01360.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.